These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32067544)

  • 1. Glioma tumor proteomics: clinically useful protein biomarkers and future perspectives.
    Ghantasala S; Gollapalli K; Epari S; Moiyadi A; Srivastava S
    Expert Rev Proteomics; 2020 Mar; 17(3):221-232. PubMed ID: 32067544
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches.
    Pirlog R; Susman S; Iuga CA; Florian SI
    Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31357616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma proteomics: status and perspectives.
    Niclou SP; Fack F; Rajcevic U
    J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
    Kalinina J; Peng J; Ritchie JC; Van Meir EG
    Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
    Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
    Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets.
    Vecera M; Sana J; Lipina R; Smrcka M; Slaby O
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine.
    Chang SM; Cahill DP; Aldape KD; Mehta MP
    Am Soc Clin Oncol Educ Book; 2016; 35():75-81. PubMed ID: 27249688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteomic landscape of renal tumors.
    Chinello C; L'imperio V; Stella M; Smith AJ; Bovo G; Grasso A; Grasso M; Raimondo F; Pitto M; Pagni F; Magni F
    Expert Rev Proteomics; 2016 Dec; 13(12):1103-1120. PubMed ID: 27748142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p SRM, SWATH and HRM -  targeted proteomics approaches on TripleTOF 5600+ mass spectrometer and their applications in oncology research].
    Faktor J; Michalova E; Bouchal P
    Klin Onkol; 2014; 27 Suppl 1():S110-5. PubMed ID: 24945547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy.
    Pai MGJ; Biswas D; Verma A; Srivastava S
    Expert Rev Proteomics; 2023; 20(12):381-395. PubMed ID: 37970632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How may targeted proteomics complement genomic data in breast cancer?
    Guerin M; Gonçalves A; Toiron Y; Baudelet E; Audebert S; Boyer JB; Borg JP; Camoin L
    Expert Rev Proteomics; 2017 Jan; 14(1):43-54. PubMed ID: 27813428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.
    Gahoi N; Malhotra D; Moiyadi A; Varma SG; Gandhi MN; Srivastava S
    Proteomics Clin Appl; 2018 May; 12(3):e1700056. PubMed ID: 28679024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
    Mohri Y; Toiyama Y; Kusunoki M
    Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.